Table 2.
Democratic Republic of the Congo (n=750) | Gabon (n=752) | Total (n=1502) | |
---|---|---|---|
Number of episodes with an infection | |||
Plasmodium falciparum | 717 (95·6%) | 702 (93·4%) | 1419 (94·5%) |
Plasmodium malariae | 69 (9·2%) | 59 (7·8%) | 128 (8·5%) |
Plasmodium ovale curtisi | 20 (2·7%) | 27 (3·6%) | 47 (3·1%) |
Plasmodium ovale wallikeri | 16 (2·1%) | 11 (1·5%) | 27 (1·8%) |
Plasmodium vivax | 0 | 0 | 0 |
Number of episodes with mono-infection | |||
P falciparum | 621 (82·8%) | 616 (81·9%) | 1237 (82·4%) |
P malariae | 1 (0·1%) | 5 (0·7%) | 6 (0·4%) |
P ovale curtisi | 0 | 2 (0·3%) | 2 (0·1%) |
P ovale wallikeri | 0 | 1 (0·1%) | 1 (0·1%) |
P vivax | 0 | 0 | 0 |
No parasites found | 31 (4·1%) | 42 (5·6%) | 73 (4·9%) |
Number of episodes with mixed infections | |||
P falciparum plus P malariae | 61 (8·1%) | 51 (6·8%) | 112 (7·5%) |
P falciparum plus P ovale spp | 29 (3·9%) | 32 (4·3%) | 61 (4·1%) |
P falciparum plus P malariae plus P ovale spp | 6 (0·8%) | 3 (0·4%) | 9 (0·6%) |
P malariae plus P ovale curtisi | 1 (0·1%) | 0 | 1 (0·1%) |
Data are n (%) for the post-hoc intention-to-treat analysis set. P ovale spp values below the limit of quantification (<5 per μL) were imputed as 4·9 per μL.